Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2248235

IR number 1643147
Words CRISPR BY DESIGN
Image
Image description
Status protected: Registered/protected
Priority date 23 Mar 2021 (Convention)
Classes 5, 42, 44
Kind Word
Dates
Renewal due 22 Sep 2031
Registration advertised / published 27 Apr 2022
Entered on Register 27 Apr 2022
Acceptance advertised / published 17 Feb 2022
Acceptance 17 Feb 2022
IR notification 10 Feb 2022
Filing 22 Sep 2021
Registered from 22 Sep 2021

Owner Address for service
Scribe Therapeutics Inc.

IR Contact

John Paul Oleksiuk Cooley LLP


Goods & Services
Class 5: Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics; gene therapy products, namely, biological preparations based on engineered cells for medical use in immuno oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including neurological disorders, huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, alzheimer's, parkinson's, ataxia, autism, epilepsy, pain, and also including cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders.
Class 42: Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; design and development of engineered cells for use in scientific research and drug discovery and development; providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; molecular diagnostic services for medical research purposes.
Class 44: Molecular diagnostic services for medical purposes; medical diagnostic testing services in the field of human disease and human medical conditions.

Convention details
Date 23 Mar 2021
Number 90596751
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image